Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 293

1.

Basal insulin analogues in the management of diabetes mellitus: What progress have we made?

Owens DR, Matfin G, Monnier L.

Diabetes Metab Res Rev. 2014 Feb;30(2):104-19. doi: 10.1002/dmrr.2469. Review.

PMID:
24026961
3.

Insulin glargine: a systematic review of a long-acting insulin analogue.

Wang F, Carabino JM, Vergara CM.

Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.

PMID:
12860485
4.

Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.

Horvath K, Jeitler K, Berghold A, Ebrahim SH, Gratzer TW, Plank J, Kaiser T, Pieber TR, Siebenhofer A.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005613. Review.

PMID:
17443605
5.

Degludec, a new ultra-long-acting basal insulin for the treatment of diabetes mellitus type 1 and 2: advances in clinical research.

Muñoz Torres M.

Endocrinol Nutr. 2014 Mar;61(3):153-9. doi: 10.1016/j.endonu.2013.03.012. Epub 2013 Jul 25. Review.

PMID:
23890782
6.

Insulin detemir: a review of its use in the management of diabetes mellitus.

Keating GM.

Drugs. 2012 Dec 3;72(17):2255-87. doi: 10.2165/11470200-000000000-00000. Review.

PMID:
23110609
7.

The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes?

Maiorino MI, Petrizzo M, Capuano A, Giugliano D, Esposito K.

Expert Opin Biol Ther. 2014 Jun;14(6):799-808. doi: 10.1517/14712598.2014.895812. Epub 2014 Mar 27. Review.

PMID:
24673155
8.

Insulin detemir: a review of its use in the management of type 1 and 2 diabetes mellitus.

Chapman TM, Perry CM.

Drugs. 2004;64(22):2577-95. Review.

PMID:
15516157
9.

A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review.

Frier BM, Russell-Jones D, Heise T.

Diabetes Obes Metab. 2013 Nov;15(11):978-86. doi: 10.1111/dom.12106. Epub 2013 May 1. Review.

PMID:
23551900
10.

Spotlight on insulin glargine in type 1 and 2 diabetes mellitus.

McKeage K, Goa KL.

Treat Endocrinol. 2002;1(1):55-8. Review.

PMID:
15765621
11.

Revisiting the efficacy of long-acting insulin analogues on adults with type 1 diabetes using mixed-treatment comparisons.

Sanches AC, Correr CJ, Venson R, Pontarolo R.

Diabetes Res Clin Pract. 2011 Dec;94(3):333-9. doi: 10.1016/j.diabres.2011.09.001. Epub 2011 Oct 11. Review.

PMID:
21992870
12.

Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis.

Monami M, Marchionni N, Mannucci E.

Diabetes Obes Metab. 2009 Apr;11(4):372-8. doi: 10.1111/j.1463-1326.2008.00976.x. Review.

PMID:
19267715
13.

Flexibly timed once-daily dosing with degludec: a new ultra-long-acting basal insulin.

Josse RG, Woo V.

Diabetes Obes Metab. 2013 Dec;15(12):1077-84. doi: 10.1111/dom.12114. Epub 2013 May 6. Review.

PMID:
23577589
14.

A meta-analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia.

Heller S, Mathieu C, Kapur R, Wolden ML, Zinman B.

Diabet Med. 2016 Apr;33(4):478-87. doi: 10.1111/dme.13002. Epub 2015 Dec 13.

15.

Defining the role of insulin detemir in Basal insulin therapy.

Morales J.

Drugs. 2007;67(17):2557-84. Review.

PMID:
18034591
16.

The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.

Baxter MA.

Acta Diabetol. 2008 Dec;45(4):253-68. doi: 10.1007/s00592-008-0052-9. Epub 2008 Sep 3. Review.

PMID:
18766296
17.

Insulin degludec, a long-acting once-daily basal analogue for type 1 and type 2 diabetes mellitus.

Berard L, MacNeill G.

Can J Diabetes. 2015 Feb;39(1):4-9. doi: 10.1016/j.jcjd.2014.02.019. Epub 2014 Jul 22.

PMID:
25065475
18.

Spotlight on insulin detemir in type 1 and 2 diabetes mellitus.

Chapman TM, Perry CM.

BioDrugs. 2005;19(1):67-9.

PMID:
15691219
19.

Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage study.

Haukka J, Hoti F, Erästö P, Saukkonen T, Mäkimattila S, Korhonen P.

Pharmacoepidemiol Drug Saf. 2013 Dec;22(12):1326-35. doi: 10.1002/pds.3534. Epub 2013 Oct 21.

20.

Insulin degludec. Uncertainty over cardiovascular harms.

[No authors listed]

Prescrire Int. 2014 Jun;23(150):149.

PMID:
25121146

Supplemental Content

Support Center